Ex vivo breast cancer cell purging by adenovirus-mediated cytosine deaminase gene transfer and short-term incubation with 5-fluorocytosine completely prevents tumor growth after transplantation

Human Gene Therapy

Volumn 9, Issue 15, 1998, Pages 2277-2284

  Wolff, Gerhard ^a,b   Körner, Ida J ^a   Schumacher, Axel ^a   Arnold, Wolfgang ^c   Dörken, Bernd ^a,b   Mapara, Markus Y ^a,b,d  

^a HUMBOLDT UNIVERSITY   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c HepaVec AG   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; EPITHELIUM CELL; GENE TRANSFER; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; TUMOR GROWTH;

ADENOVIRIDAE; ANIMALIA;

EID: 0032505743     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.15-2277     Document Type: Article

References (11)

1. BERNAD, A., VARAS, F., GALLEGO, J.M., ALMENDRAL, J.M., and BUEREN, J.A. (1994). Ex vivo expansion and selection of retrovirally transduced bone marrow: An efficient methodology for gene-transfer to murine lympho-haemopoietic stem cells. Br. J. Haematol. 87, 6-17.
2. BRAND, K., ARNOLD, W., BARTELS, T., LIEBER, A., KAY, M.A., STRAUSS, M., and DÖRKEN, B. (1997). Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors. Cancer Gene Ther. 4, 9-16.
3. BREGNI, M., SIENA, S., FORMOSA, A., LAPPI, D.A., MARTINEAU, D., MALAVASI, F., DÖRKEN, B., BONADONNA, G., and GIANNI, A.M. (1989). B cell restricted saporin immunotoxins: Activity against B cell lines and chronic lymphocytic leukemia cells. Blood 73, 753-762.
4. + cells.Gene Ther. 5, 465-472.
5. BRENNER, M.K., RILL, D.R., MOEN, R.C., KRANCE, R.A., MIRRO, J., ANDERSON, W.F., and IHLE, J.N. (1993). Gene-marking to trace origin of relapse after autologous bone marrow transplantation. Lancet 341, 85-86.
6. CHEN, L., CHEN, D., MANOME, Y., DONG, Y., FINE, H.A., and KUFE, D.W. (1995). Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter. J. Clin. Invest. 96, 2775-2782.
7. CHEN, L., PULSIPHER, M., CHEN, D., SIEFF, C., ELIAS, A., FINE, H.A., and KUFE, D.W. (1996). Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources. J. Clin. Invest. 98, 2539-2548.
8. s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells. Proc. Natl. Acad. Sci. U.S.A. 92, 11024-11028.
9. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83, 3068-3076.
10. DELPORTE, C., REDMAN, R.S., and BAUM, B.J. (1997). Relationship between the cellular distribution of the alpha(v)beta3/5 integrins and adenoviral infection in salivary glands. Lab. Invest. 77, 167-173.
11. s gene therapy induces apoptosis of human mammary tumors in nude mice. Cancer Res. 56, 1965-1969.